Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

Status:

Topic selection

Technology type:

Medicine

Decision:

Not selected

Reason for decision:

Not eligible for Health Technology Evaluation guidance

Further information:

Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. This decision follows consideration of your product against the eligibility criteria. Please see the NICE wide topic prioritisation manual section 7.1.3 for more information on the eligibility and section criteria for technologies. Section 7.1.3 of the NICE-wide topic prioritisation: the manual states that new medicines that meet the criteria will be selected for assessment by the technology appraisal programme, except when there is a clear rationale not to do so. For example, it is appropriate to assess the medicine within a NICE guideline (for example, a new medicine within an existing class)

ID number:

12034

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email [email protected]

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about prioritising our guidance topics